Ernexa Therapeutics Inc.: Form 8-K, filed Oct 5, 2023
Filed with the SEC on Oct 5, 2023 and accepted by EDGAR at Oct 5, 2023, 16:30 ET.
Items reported
- Item 3.01 Delisting notice
- Item 5.02 Departure or appointment of officers or directors
- Item 8.01 Other events
Sections
Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. The main document on sec.gov.
Source: SEC EDGAR, the filing index for accession 0001140361-23-047156. Last ingested by Listed: Oct 30, 2026, 14:05 ET. Listed shows no prices and gives no investment advice.